Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

IONTRAC

Financiado

Cerrado

Ion Transport Proteins in Control of Cancer Cell Behaviour

"With over 3 million new cases and 1.5 million arising deaths each year in Europe, cancer is a major public health problem with an urgent need for new therapies. This proposal builds upon mounting evidence that ion channels and tr... ver más

30/09/2015

WWU

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

Westfälische Wilhelms-Universität Münster No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 10 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-09-30 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

10 Participantes

WWU

608.85K€ | Lider

BAYER

N.D. | Participante

UOXF

N.D. | Participante

MPG

N.D. | Participante

Proyectos interesantes

MetaIron

Medical Technol...

Data Science

150K€ Cerrado

REPANCAN

Medical Technol...

Data Science

140K€ Cerrado

pHioniC

Medical Technol...

Applied Physics

4M€ Cerrado

BasicFit

Medical Technol...

Data Science

150K€ Cerrado

PROTAC-PDAC

Medical Technol...

Data Science

2M€ Cerrado

BALaNCE

Medical Technol...

Data Science

150K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

Westfälische Wilhelms-Universität Münster No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "With over 3 million new cases and 1.5 million arising deaths each year in Europe, cancer is a major public health problem with an urgent need for new therapies. This proposal builds upon mounting evidence that ion channels and transporters underlie many of the hallmarks of cancer. Thus, proteins involved in membrane transport, long known as important drug targets in other pathologies (channelopathies), are a new class of therapeutic and/or diagnostic targets in oncology. IonTraC is first to propose a systematic analysis of the expression, function, as well as therapeutic and diagnostic potential of proteins involved in ion transport (the ""transportome"") in cancer. This paradigm will be implemented in pancreatic ductal adenocarcinoma (PDAC) which has one of the worst prognoses of all cancers, with an overall 5-year survival rate of less than 5%. IonTraC thereby provides the framework for an inter- and supra-disciplinary training for early stage researchers in a highly innovative, exponentially growing field in oncology which will have a major impact on other disciplines such as immunology and angiology as well. The main objectives of IonTraC are: • to provide a scientific and methodological platform for supra-disciplinary training of early stage researchers in and beyond the fields of ion transport and oncology • to provide an inter-sectoral training programme with special focus on career development of young researchers • to determine the concerted expression and function of ion channels and transporters required for the progression of PDAC, and • to provide validated therapeutic and diagnostic concepts and tools that are based on transport proteins serving as novel drug targets and/or biomarkers."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores